Zentrum für Quantitative Biologie

Christopher Mohr

Forschung

Kontakt:

+49-7071-29-78652

christopher.mohr@qbic.uni-tuebingen.de

www.qbic.uni-tuebingen.de

Biographie:

  • Seit 2018: Institut für Translationale Bioinformatik/ Zentrum für Quantititative Biologie (QBiC)
  • 2012-2018: Doktorand, Angewandte Bioinformatik Gruppe, Zentrum für Bioinformatik, Tübingen
  • 2009-2012: M.Sc. Studium der Bioinformatik, Universität Tübingen
  • 2006-2009: B.Sc. Studium der Bioinformatik, Universität Tübingen

Publikationen:

Detaillierte Infos hierzu auch auf meinem Google Scholar Profil.

  • Schneider, L., Kehl, T., Thedinga, K., Grammes, N. L., Backes, C., Mohr, C., … Lenhof, H.-P. (2019). ClinOmicsTrailbc: a visual analytics tool for breast cancer treatment stratification. Bioinformatics.
  • Rabsteyn, A., Kyzirakos, C., Schroeder, C., Sturm, M., Mohr, C., Matthes, J., … Lang, P. (2019). Abstract B124: Personalized peptide vaccination based on patient-individual tumor-specific variants induces T-cell responses in pediatric patients. In Novel Vaccine Platforms and Combinations. American Association for Cancer Research.
  • Blaeschke, F., Paul, M. C., Schuhmann, M. U., Rabsteyn, A., Schroeder, C., Casadei, N., Matthes, J., Mohr, C., … Feuchtinger, T. (2019). Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy. Cytotherapy.
  • Löffler, M. W., Mohr, C., Bichmann, L., Freudenmann, L. K., Walzer, M., … Rammensee, H.-G. (2019). Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma. Genome Medicine, 11(1).
  • Mohr, C., Friedrich, A., Wojnar, D., Kenar, E., Polatkan, A. C., Codrea, M. C., Czemmel, S., Kohlbacher, O., and Nahnsen, S. (2018). qPortal: A platform for data-driven biomedical research. PloS one, 13(1), e0191603.
  • Armeanu-Ebinger, S., Hadaschik, D., Kyzirakos, C., Mohr, C. et. al (2017). Number of predicted tumour-neoantigens as biomarker for cancer immunotherapies. Annals of Oncology, Vol. 28(suppl_7), 12-12.
  • Schubert, B., de la Garza, L., Mohr, C., Walzer, M., and Kohlbacher, O. (2017). ImmunoNodes–graphical development of complex immunoinformatics workflows. BMC bioinformatics, 18(1), 242.
  • Löffler, M.W., Chandran, P.A., Laske, K., ... , Mohr, C. et. al (2016). Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient. Journal of hepatology, 65(4), 849-855.
  • Kyzirakos, C., Mohr, C. et. al (2016). Optimized neoantigen selection based on tumor exome data. Annals of Oncology, 27(suppl_6).
  • Schubert, B., Walzer, M., Brachvogel, H.P., Szolek, A., Mohr, C. and Kohlbacher, O. (2016). FRED 2: an immunoinformatics framework for Python. Bioinformatics. Bioinformatics, 32(13), 2044-2046.
  • Rabsteyn, A., Kyzirakos, C., Schröder, C., Sturm, M., Mohr, C. et. al (2016). Abstract A113: iVacALL: A personalized peptide-vaccination design platform for pediatric acute lymphoblastic leukemia patients based on patient- individual tumor-specific variants. Cancer Immunology Research, 4(1 Supplement), A113.
  • Szolek, A., Schubert, B., Mohr, C., Sturm, M., Feldhahn, M., and Kohlbacher, O. (2014). OptiType: precision HLA typing from next-generation sequencing data. Bioinformatics, 30(23), 3310-3316.
  • Olabarriaga, S.D., Benabdelkader, A., Caan, M.W., Jaghoori, M.M., Krüger, J., de la Garza, L., Mohr, C. et. al (2014). WS-PGRADE/gUSE- Based Science Gateways in Teaching. In Science Gateways for Distributed Computing Infrastructures, Springer, Cham., 223-234.
  • Kyzirakos, C., Pflückhahn, U., Sturm, M., Schroeder, C., Bauer, P., Walter, M., Feld- hahn, M., Walzer, M., Mohr, C. et. al (2013). iVacALL: utilizing next- generation sequencing for the establishment of an individual peptide vaccination approach for paediatric acute lymphoblastic leukaemia. Bone Marrow Transplan- tation, 48, S401.